Address: No. 1, Tung Hsing St., Shulin, Taipei Hsien, Taiwan, R.O.C.
Tel: +886-2-86843318
FAX: +886-2-86843202
Est. Year: 1964
Capital: NT$ 920,000,000
Chief Executive Officer: Mr. Derek Wang
Board Chairman: Mr. Derek Wang
General Manager: Dr. Steve H. Chang
Sales Manager: Mr. Denry Huang
Trade Mark: CCSB
Products:
Fermentation products : Pravastatin, Rapamycin, Mycophenolate Acid, Lovastatin, API : Calcium Polycarbophil, Dexbrompheniramine Maleate, Mycophenolate Mofetil, API : Acetaminophen, Guaifenesin, Methocarbamol, Carisoprodol, API : Benzalkonium Chloride 50%, Nifedipine, Fluoxetin, Alprazolam, Fluconazole, API : Glipizide, Glibenclamide, Bucetin, Oxaprozin, Sodium Starch Glycolate, API contract manufacturing.
Company Profile:
CCSB founded in 1964, is the largest bulk pharmaceutical (API) manufacturer in Taiwan, located in the suburb of Taipei with a munufacturing site of 8.7 acres. CCSB is a FDA approved cGMP API plantto produce synthesis and biotechnology products.
